Toshio Hirano Selected Research

Toshio Hirano Research Topics

Disease

13	Inflammation (Inflammations) 01/2021 - 08/2002
13	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 08/2002
11	Arthritis (Polyarthritis) 02/2015 - 08/2002
8	Neoplasms (Cancer) 01/2021 - 09/2002
7	Rheumatoid Arthritis 02/2015 - 04/2002
5	Infections 01/2021 - 09/2004
3	Hypersensitivity (Allergy) 01/2012 - 07/2006
3	Neoplasm Metastasis (Metastasis) 06/2008 - 07/2006
2	Cytokine Release Syndrome 01/2021 - 01/2020
2	COVID-19 11/2020 - 01/2020
2	Multiple Sclerosis 02/2015 - 01/2012
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 02/2015 - 08/2002
2	Bronchiolitis Obliterans 05/2013 - 08/2012
2	Acute-Phase Reaction 03/2009 - 08/2002
2	Breast Neoplasms (Breast Cancer) 05/2007 - 05/2004
1	Obesity 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Pain (Aches) 08/2015
1	Type 2 Diabetes Mellitus (MODY) 10/2013
1	Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos) 11/2011
1	Hypogonadism (Hypergonadotropic Hypogonadism) 10/2011
1	Anaphylaxis (Anaphylactic Shock) 07/2011
1	Contact Dermatitis (Eczema, Contact) 07/2011
1	Ischemia 03/2011
1	Necrosis 03/2011
1	Hypertrophy 08/2010
1	Colitis 02/2010
1	T-Cell Leukemia (Leukemia, T Cell) 01/2010
1	Autoimmune Diseases of the Nervous System 03/2009
1	Septic Shock (Toxic Shock Syndrome) 01/2009
1	Foodborne Diseases 01/2009
1	Leukemia 07/2007
1	Intellectual Disability (Idiocy) 05/2007
1	Eosinophilia 05/2007
1	HIV Infections (HIV Infection) 07/2006
1	Joint Diseases (Joint Disease) 06/2006
1	Splenomegaly 03/2004
1	Cardiomegaly (Heart Hypertrophy) 08/2003
1	Carcinogenesis 03/2003
1	Multiple Myeloma 08/2002
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 08/2002

Drug/Important Bio-Agent (IBA)

18	Interleukin-6 (Interleukin 6)IBA 01/2021 - 08/2002
15	CytokinesIBA 01/2021 - 08/2002
7	ChemokinesIBA 08/2015 - 01/2012
4	Interleukin-17 (Interleukin 17)IBA 01/2014 - 01/2010
4	Proteins (Proteins, Gene)FDA Link 11/2011 - 05/2004
3	zinc-binding protein (zinc binding protein)IBA 11/2011 - 05/2004
3	AntigensIBA 01/2011 - 08/2002
3	Cytokine Receptor gp130IBA 01/2010 - 03/2004
3	Tyrosine (L-Tyrosine)FDA Link 07/2007 - 03/2004
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2021 - 05/2013
2	NF-kappa B (NF-kB)IBA 01/2021 - 01/2020
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2015 - 03/2003
2	InterleukinsIBA 01/2014 - 06/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 03/2011
2	ZincIBA 10/2011 - 05/2007
2	Interleukin-7 (Interleukin 7)IBA 03/2009 - 06/2006
2	Interleukin-2 (IL2)IBA 06/2008 - 07/2006
2	ErbB Receptors (EGF Receptor)IBA 07/2007 - 03/2003
2	AutoantibodiesIBA 03/2004 - 04/2002
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	DiamondIBA 11/2020
1	EpiregulinIBA 02/2015
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 02/2015
1	TenascinIBA 02/2015
1	AmphiregulinIBA 02/2015
1	BetacellulinIBA 02/2015
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2014
1	Insulin (Novolin)FDA Link 10/2013
1	Staphylococcal Protein A (Protein A)IBA 11/2011
1	Trace Elements (Biometals)IBA 10/2011
1	Actins (F Actin)IBA 08/2010
1	Collagen Type II (Type II Collagen)IBA 05/2010
1	VaccinesIBA 03/2009
1	Toll-Like Receptors (Toll-Like Receptor)IBA 03/2009
1	SuperantigensIBA 01/2009
1	MetalsIBA 08/2008
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 06/2008
1	AntibodiesIBA 06/2008
1	Diphtheria ToxinIBA 06/2008
1	Epidermal Growth Factor (EGF)IBA 07/2007
1	cimaglerminIBA 07/2007
1	Messenger RNA (mRNA)IBA 05/2007
1	Immunoglobulin E (IgE)IBA 05/2007
1	Chelating AgentsIBA 07/2006
1	ethylenediamine (ethylenediamine dihydroiodide)FDA Link 07/2006
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 07/2006
1	p38 Mitogen-Activated Protein KinasesIBA 11/2004
1	Serine (L-Serine)FDA Link 11/2004
1	Leukemia Inhibitory FactorIBA 08/2003
1	AgarIBA 03/2003
1	Cytokine Receptors (Cytokine Receptor)IBA 10/2002
1	Cyclin D1IBA 09/2002

Therapy/Procedure

1	Extracorporeal Membrane Oxygenation 11/2020
1	Artificial Respiration (Mechanical Ventilation) 11/2020
1	Therapeutics 01/2019
1	Heterotopic Transplantation 08/2012
1	Aftercare (After-Treatment) 06/2008
1	Immunotherapy 07/2006